Recent Placements
Rarified Air
For over 20 years, CenterPeak’s founders have been the driving force behind the most significant office openings, group acquisitions and partner placements across the United States. We’ve placed over 2,000 partners and opened more than 40 offices for Am Law 50 firms, with combined practices worth billions of dollars.
Selected Recent Placements
The Federal Aviation Administration's former chief counsel Marc Nichols has joined DLA Piper in Washington, D.C., as partner and co-chair of its transportation practice. Mr. Nichols joins DLA Piper with more than 25 years of public- and private-sector experience, including serving as in-house counsel for international heavyweights in the aerospace, defense and technology industries.
Mathew Eapen joins Sidley Austin as a partner in its Investment Funds practice. Mr. Eapen’s practice focuses on advising private investment funds, particularly venture capital, growth equity, and technology- and health care-focused funds, and emerging companies on all aspects of their business, including capital raising, investment activity, and other operational and transactional matters.
Carl Morales has joined Goodwin’s Life Sciences practice, as a partner in the New York office. Mr. Morales has particular expertise in developing and prosecuting complex patent portfolios for small molecule drug products, including for products involved or expected to be involved in litigation. He devises and executes strategies to secure second and third generation patent coverage that extends pharmaceutical product exclusivity. He also routinely conducts due diligence on life science patent portfolios for a variety of transactions, including licensing deals, acquisitions, investments and royalty purchases.
David Grubman and Adam Cromie join Sidley’s M&A practice as partners in the New York office. Mr. Grubman joins from Jones Day, where he was M&A Chair for the Americas for the firm’s corporate practice. He will be global co-leader of Sidley’s M&A practice. Mr. Cromie joins from Simpson Thacher, where he was an M&A partner. He worked with Mr. Grubman previously for seven years. Mr. Grubman advises companies in a broad range of complex and bet-the-company transactions, including takeover defense, proxy contests, and corporate governance matters. He is widely recognized as a leading M&A lawyer in the United States and globally. Mr. Cromie’s practice focuses on advising public and private companies and boards of directors across a variety of M&A transactional matters, including mergers, acquisitions, divestitures, joint ventures, and majority and minority investments.
Elizabeth “Liz” Stotland Weiswasser and Anish R. Desai join the firm as partners in its Litigation Department, resident in New York. Ms. Weiswasser, who will be co-chair of the Litigation Department, and Mr. Dai are nationally recognized for their success representing life sciences and technology clients in their most significant complex commercial disputes.
Jim Fogarty joins the firm’s New York office as a partner in the Structured Finance Practice. Mr. Fogarty represents private equity sponsors, private capital lenders, financial institutions, asset managers, and corporates in complex structured and securitization transactions.
Lesley Janzen joins the firm as partner in the New York office, focusing on capital markets transactions. Her transactional practice focuses on high-yield debt offerings and equity transactions for both issuers and underwriters. She regularly advises sponsors, investment banks, investors and issuers in equity and debt offerings, including IPOs, leveraged buyouts and liability management transactions.
Senior mergers and acquisitions lawyer and former Wachtell partner Gordon Moodie joins New York office as a partner in the Mergers & Acquisitions Group and Public Company Advisory Group. Mr. Moodie will advise the firm’s clients, including public companies, boards, special committees and private equity sponsors, on the full spectrum of M&A transactions, including those in the technology and AI sectors and with complex corporate governance aspects.